1. Home
  2. TVTX vs UVV Comparison

TVTX vs UVV Comparison

Compare TVTX & UVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • UVV
  • Stock Information
  • Founded
  • TVTX 2008
  • UVV 1886
  • Country
  • TVTX United States
  • UVV United States
  • Employees
  • TVTX N/A
  • UVV N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • UVV Farming/Seeds/Milling
  • Sector
  • TVTX Health Care
  • UVV Industrials
  • Exchange
  • TVTX Nasdaq
  • UVV Nasdaq
  • Market Cap
  • TVTX 1.5B
  • UVV 1.3B
  • IPO Year
  • TVTX N/A
  • UVV N/A
  • Fundamental
  • Price
  • TVTX $24.64
  • UVV $55.40
  • Analyst Decision
  • TVTX Strong Buy
  • UVV
  • Analyst Count
  • TVTX 16
  • UVV 0
  • Target Price
  • TVTX $35.20
  • UVV N/A
  • AVG Volume (30 Days)
  • TVTX 2.7M
  • UVV 219.4K
  • Earning Date
  • TVTX 10-30-2025
  • UVV 08-06-2025
  • Dividend Yield
  • TVTX N/A
  • UVV 5.93%
  • EPS Growth
  • TVTX N/A
  • UVV N/A
  • EPS
  • TVTX N/A
  • UVV 4.11
  • Revenue
  • TVTX $333,865,000.00
  • UVV $2,943,996,000.00
  • Revenue This Year
  • TVTX $83.87
  • UVV $1.52
  • Revenue Next Year
  • TVTX $40.99
  • UVV $0.97
  • P/E Ratio
  • TVTX N/A
  • UVV $13.46
  • Revenue Growth
  • TVTX 87.94
  • UVV 4.11
  • 52 Week Low
  • TVTX $12.91
  • UVV $49.40
  • 52 Week High
  • TVTX $28.69
  • UVV $67.33
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 59.38
  • UVV 49.98
  • Support Level
  • TVTX $23.22
  • UVV $55.13
  • Resistance Level
  • TVTX $25.10
  • UVV $56.48
  • Average True Range (ATR)
  • TVTX 1.27
  • UVV 1.01
  • MACD
  • TVTX -0.23
  • UVV 0.02
  • Stochastic Oscillator
  • TVTX 63.75
  • UVV 45.27

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About UVV Universal Corporation

Universal Corp is an international leaf tobacco supplier. The company procures leaf tobacco from farmers, processes it, and sells it to companies that manufacture consumer tobacco products. Universal does not manufacture or sell any consumer products itself. The company's segments include Tobacco Operations and Ingredients Operations. It generates maximum revenue from the Tobacco Operations segment. Geographically, it derives a majority of revenue from the United States. The company operates in the USA, Belgium, China, Egypt, Philippines, Germany, and Other Countries with majority of revenue from USA.

Share on Social Networks: